Monday, 31 August 2026European Markets

AVENIR TELECOM Stock Is 28% Up In The Last 21 Sessions

Loading stream...

(vianews) - shares of avenir telecom (cac 40: avt.pa) jumped by a staggering 28.21% in 21 sessions from €0.16 to €0.20 at 05:38 est on wednesday, following the last session's upward trend. cac 40 is falling 0.23% to €7,369.93, after two successive sessions in a row of losses.

about avenir telecom

avenir telecom s.a. designs and distributes mobile phones and mobility accessories in europe, the middle east, africa, asia, oceania, and the americas. the company also provides chargers, cables, memory cards, and screen protectors. it offers its products under the energizer brand. the company was incorporated in 1989 and is headquartered in marseille, france.

earnings per share

as for profitability, avenir telecom has a trailing twelve months eps of €163.92.

volatility

avenir telecom's last week, last month's, and last quarter's current intraday variation average was 5.74%, 2.33%, and 5.31%.

avenir telecom's highest amplitude of average volatility was 7.77% (last week), 5.50% (last month), and 5.31% (last quarter).

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, avenir telecom's stock is considered to be overbought (>=80).

more news about avenir telecom (avt.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com